OMADA HEALTH INC SEC Filings

Omada Health, Inc. Chief Financial Officer Steven L. Cook reported a sale of 4,211 shares of the company’s common stock on 12/10/2025 at a weighted average price of $15.3657 per share. The sale was coded as an open market or private sale transaction and was made pursuant to a Rule 10b5-1 trading plan adopted by Cook on 08/15/2025.

The transaction was executed in multiple trades at prices ranging from $15.24 to $15.55 per share. Following this sale, Cook beneficially owns 57,566 shares of Omada Health common stock in direct ownership.

Omada Health, Inc. reported an insider stock sale by Chief Executive Officer and director Sean P. Duffy. On December 10, 2025, he sold 9,266 shares of common stock at a weighted average price of $15.3657 per share in an open-market transaction coded S.

The sale was made under a Rule 10b5-1 trading plan adopted on August 15, 2025. After this transaction, Duffy beneficially owned 126,644 shares directly and 861,109 shares indirectly through family trusts for the benefit of his family members, and he disclaims beneficial ownership of the trust-held shares except to the extent of his pecuniary interest.

Omada Health (OMDA) reported Q3 2025 results showing strong top-line growth and improved losses. Revenue for the three months ended September 30, 2025 rose to $68.0 million from $45.5 million a year ago, driven by services revenue of $62.9 million and hardware revenue of $5.1 million. Gross profit increased to $45.1 million from $28.6 million.

Operating loss narrowed to $2.5 million from $8.5 million, and net loss improved to $3.2 million from $9.2 million. Basic and diluted net loss per share was $(0.06) (vs. $(1.18)), reflecting a larger post‑IPO share count.

Liquidity strengthened materially. Cash and cash equivalents were $198.6 million at quarter‑end (vs. $76.4 million at December 31, 2024). The company completed an IPO on June 9, 2025, generating $151.6 million in net proceeds and subsequently repaid its MidCap term loan and revolver, recording a $2.1 million loss on debt extinguishment. Accounts receivable increased to $41.4 million, with significant contributions from affiliates of The Cigna Group. Shares outstanding were 57,908,047 as of November 5, 2025.

Omada Health, Inc. (OMDA) reported that it issued a press release announcing financial results for the three months ended September 30, 2025. The press release is furnished as Exhibit 99.1 to a Form 8-K under Item 2.02 and, as stated, is furnished and not deemed filed under Section 18 of the Exchange Act, nor incorporated by reference except as specifically referenced.

Jonathan D. Root, a director of Omada Health, Inc. (OMDA), reported the receipt of 657 restricted stock units (RSUs) on 10/05/2025 issued under the company's Non-Employee Director Compensation Program in lieu of retainer fees. Following this grant, Mr. Root directly beneficially owns 10,630 shares and indirectly beneficially owns 4,717, (4,571,769 + 146,257) shares through affiliated USVP X funds, where he is a managing member of the general partner and disclaims direct beneficial ownership except for any pecuniary interest. The Form 4 was signed by an attorney-in-fact on 10/07/2025.

Insider transaction summary: A Form 4 shows that Trevor Fetter, a director of Omada Health, Inc. (OMDA), was granted 712 restricted stock units (RSUs) on 10/05/2025 as payment under the non-employee director compensation program in lieu of retainer fees. Each RSU converts to one share at settlement and the grant carried a reported price of $0 (i.e., issued as compensation). After the grant, the filing reports Mr. Fetter directly beneficially owns 10,705 shares and indirectly beneficially owns 111,200 shares through an LLC he solely controls, for a combined beneficial position of 121,905 shares.

The form was signed by an attorney-in-fact on 10/07/2025. The filing discloses that settlement timing follows plan terms and that the indirect holdings are held via the limited liability company of which Mr. Fetter is the sole member.

Insider transaction by Omada Health director Jeryl L. Hilleman: the filing reports that on 10/05/2025 the reporting person was granted 1,126 restricted stock units (RSUs) under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents the right to receive one share of common stock with settlement terms set by the Program. After the grant, the reporting person beneficially owns 11,238 shares of common stock. The RSUs were recorded at a price of $0 because they were compensation awards rather than purchases. The Form 4 was signed by an attorney-in-fact on 10/07/2025.

Steven L. Cook, Chief Financial Officer of Omada Health, Inc. (OMDA), reported a sale of shares on 09/05/2025. The Form 4 shows a disposition of 2,006 shares of common stock at a price of $24.28 per share, leaving Mr. Cook with 63,783 shares owned directly after the transaction. The filing was signed by an attorney-in-fact on 09/09/2025.

Sean P. Duffy, Omada Health insider sale disclosed. The filing shows that on 09/05/2025 Mr. Duffy, who serves as Chief Executive Officer and a Director, disposed of 4,413 shares of Omada Health common stock at a price of $24.28 per share. After the sale his reported direct beneficial ownership is 140,323 shares. The filing also reports 861,109 shares held indirectly in family trusts for the benefit of his family, which he disclaims beneficial ownership of except to the extent of any pecuniary interest. The Form 4 was signed by an attorney-in-fact on 09/09/2025.